HAE

Clinical trials for HAE explained in plain language.

Never miss a new study

Get alerted when new HAE trials appear

Sign up with your email to follow new studies for HAE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet finished but already full! 1 Completed 1

New daily pill could stop painful swelling attacks in rare disease

Disease control Completed

This study tested an oral drug called BCX4161 to prevent attacks of hereditary angioedema (HAE), a condition that causes sudden, painful swelling. Over 12 weeks, 110 adults with HAE took either a low dose, high dose, or placebo pill. Researchers tracked how many swelling attacks …

Matched conditions: HAE

Phase: PHASE2, PHASE3 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control

Last updated Jun 27, 2026 07:57 UTC

HAE

Get alerted when new HAE trials appear

New daily pill could stop painful swelling attacks in rare disease